Introduction

Prader-Willi Syndrome (PWS) is a complex genetic disorder often characterized by endocrine dysfunction. Managing Hypogonadism in Prader-Willi Syndrome remains a significant challenge for pediatricians and endocrinologists. While many adolescents enter puberty spontaneously, the majority eventually develop hypogonadism. This condition often goes underdiagnosed, leading to long-term health complications such as reduced bone mineral density.

Pubertal Development and Diagnosis

Research indicates that approximately two-thirds of adolescents with PWS begin puberty without medical intervention. Specifically, 63% of females and 68% of males achieve spontaneous onset. However, clinicians typically diagnose hypogonadism in the late teenage years. By the time patients transition to adult care, the prevalence of hypogonadism reaches 77% in females and 88% in males. The underlying cause is predominantly central hypogonadism, although some males exhibit primary or mixed etiologies.

Managing Hypogonadism in Prader-Willi Syndrome

Effective management requires consistent monitoring and timely hormone replacement therapy (HRT). Data show that 80% of females and 60% of males receive pubertal hormone replacement. Importantly, this treatment does not significantly increase behavioral or psychiatric issues. Clinicians must also address bone health, as many patients show low bone mineral density z-scores. Early detection and intervention are vital to optimize physical development and skeletal health during the transition to adulthood.

FAQ

What is the primary cause of hypogonadism in PWS?

The etiology is predominantly central hypogonadism, meaning it originates from hypothalamic or pituitary dysfunction. However, some patients may also present with primary gonadal failure.

Does hormone therapy affect behavior in PWS patients?

Studies suggest that initiating pubertal hormone replacement therapy does not result in significant changes in the frequency of behavioral or psychiatric issues in this population.

Why is bone mineral density a concern in PWS?

Adolescents with PWS often exhibit lower-than-average bone mineral density. This occurs due to hormonal deficiencies, which increases the risk of osteoporosis if not managed properly with HRT.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Nguyen H et al. Spectrum of Hypogonadism and Its Management in Adolescents With Prader-Willi Syndrome: A Retrospective Cohort Study Over 35 Years. Clin Endocrinol (Oxf). 2026 Mar 16. doi: 10.1111/cen.70131. PMID: 41839742.

Goldstone AP et al. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183-4197.

Deal CL et al. Management of Prader-Willi syndrome in childhood and adolescence. Nat Rev Endocrinol. 2013;9(11):630-645.